Rodeo is a Washington-based pharmaceutical company that researches and develops small-molecular therapeutics for the treatment of inflammatory bowel diseases.
Business Model:
Revenue: $10M
Employees: 11-50
Rodeo Therapeutics was acquired by
Amgen.
The acquisition happend on 2021-03-30.
Details of the transaction were not public
Address: 1616 Eastlake Ave E
City: Seattle
State: WA
Zip: 98102
Country: US
Rodeo is a Washington-based pharmaceutical company that researches and develops small-molecular therapeutics for the treatment of inflammatory bowel diseases.
Contact Phone:
+12069577300
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2017 | Series A | 9 | $5.9M |
AbbVie Biotech Ventures Accelerator Corp. Alexandria Venture Investments ARCH Venture Partners Eli Lilly Johnson &a; Johnson Innovation Washington Research Foundation Watson Fund WuXi AppTec AbbVie Biotech Ventures Accelerator Corp. Alexandria Venture Investments ARCH Venture Partners Eli Lilly Johnson &a; Johnson Innovation Washington Research Foundation Watson Fund WuXi AppTec |
11/2018 | Equity | $3.7M | 11/2018 | Venture Round | $8.9M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|